vs
艾伯维（ARGX）与高德纳（IT）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是高德纳的1.4倍（$2.5B vs $1.8B），艾伯维净利率更高（35.5% vs 13.8%，领先21.6%），艾伯维同比增速更快（83.2% vs 2.2%），艾伯维自由现金流更多（$322.4M vs $270.7M）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
高德纳是美国专注于商业与科技领域的研究咨询机构，服务客户覆盖大型企业、政府机构、科技公司、投资机构等群体，通过输出研究报告、举办行业峰会、提供定制咨询等形式，为客户决策提供权威专业的洞见支撑。
ARGX vs IT — 直观对比
营收规模更大
ARGX
是对方的1.4倍
$1.8B
营收增速更快
ARGX
高出81.0%
2.2%
净利率更高
ARGX
高出21.6%
13.8%
自由现金流更多
ARGX
多$51.7M
$270.7M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $1.8B |
| 净利润 | $877.2M | $242.2M |
| 毛利率 | 89.5% | 67.8% |
| 营业利润率 | 28.9% | 19.1% |
| 净利率 | 35.5% | 13.8% |
| 营收同比 | 83.2% | 2.2% |
| 净利润同比 | 1.3% | -39.2% |
| 每股收益（稀释后） | $13.25 | $3.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXIT
| Q4 25 | $2.5B | $1.8B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $1.8B | $1.7B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $1.4B | $1.7B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $901.9M | $1.6B | ||
| Q1 24 | — | $1.5B |
净利润ARGXIT
| Q4 25 | $877.2M | $242.2M | ||
| Q3 25 | — | $35.4M | ||
| Q2 25 | $414.8M | $240.8M | ||
| Q1 25 | — | $210.9M | ||
| Q4 24 | $865.6M | $398.6M | ||
| Q3 24 | — | $415.0M | ||
| Q2 24 | $-32.5M | $229.5M | ||
| Q1 24 | — | $210.5M |
毛利率ARGXIT
| Q4 25 | 89.5% | 67.8% | ||
| Q3 25 | — | 69.3% | ||
| Q2 25 | 89.2% | 68.6% | ||
| Q1 25 | — | 69.4% | ||
| Q4 24 | 90.2% | 66.8% | ||
| Q3 24 | — | 68.4% | ||
| Q2 24 | 89.4% | 68.6% | ||
| Q1 24 | — | 69.4% |
营业利润率ARGXIT
| Q4 25 | 28.9% | 19.1% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | 19.2% | 19.4% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | 8.7% | 18.5% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | -15.4% | 20.0% | ||
| Q1 24 | — | 18.6% |
净利率ARGXIT
| Q4 25 | 35.5% | 13.8% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | 23.4% | 14.3% | ||
| Q1 25 | — | 13.7% | ||
| Q4 24 | 64.1% | 23.2% | ||
| Q3 24 | — | 28.0% | ||
| Q2 24 | -3.6% | 14.4% | ||
| Q1 24 | — | 14.3% |
每股收益（稀释后）ARGXIT
| Q4 25 | $13.25 | $3.36 | ||
| Q3 25 | — | $0.47 | ||
| Q2 25 | $6.32 | $3.11 | ||
| Q1 25 | — | $2.71 | ||
| Q4 24 | $13.33 | $5.08 | ||
| Q3 24 | — | $5.32 | ||
| Q2 24 | $-0.55 | $2.93 | ||
| Q1 24 | — | $2.67 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $1.7B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3B | $319.9M |
| 总资产 | $8.7B | $8.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARGXIT
| Q4 25 | $3.5B | $1.7B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $2.1B | $2.2B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $1.5B | $1.9B | ||
| Q3 24 | — | $1.8B | ||
| Q2 24 | $1.4B | $1.2B | ||
| Q1 24 | — | $1.2B |
总债务ARGXIT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | — | — |
股东权益ARGXIT
| Q4 25 | $7.3B | $319.9M | ||
| Q3 25 | — | $556.6M | ||
| Q2 25 | $6.1B | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $5.5B | $1.4B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $4.3B | $646.7M | ||
| Q1 24 | — | $718.2M |
总资产ARGXIT
| Q4 25 | $8.7B | $8.1B | ||
| Q3 25 | — | $7.2B | ||
| Q2 25 | $7.2B | $8.3B | ||
| Q1 25 | — | $8.5B | ||
| Q4 24 | $6.2B | $8.5B | ||
| Q3 24 | — | $7.8B | ||
| Q2 24 | $4.8B | $7.4B | ||
| Q1 24 | — | $7.7B |
负债/权益比ARGXIT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | $294.5M |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $270.7M |
| 自由现金流率自由现金流/营收 | 13.0% | 15.4% |
| 资本支出强度资本支出/营收 | 0.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 0.37× | 1.22× |
| 过去12个月自由现金流最近4个季度 | $594.5M | $1.2B |
8季度趋势，按日历期对齐
经营现金流ARGXIT
| Q4 25 | $323.3M | $294.5M | ||
| Q3 25 | — | $298.7M | ||
| Q2 25 | $361.8M | $383.6M | ||
| Q1 25 | — | $313.5M | ||
| Q4 24 | $41.9M | $335.4M | ||
| Q3 24 | — | $590.8M | ||
| Q2 24 | $-124.7M | $370.0M | ||
| Q1 24 | — | $188.8M |
自由现金流ARGXIT
| Q4 25 | $322.4M | $270.7M | ||
| Q3 25 | — | $269.3M | ||
| Q2 25 | $356.6M | $347.3M | ||
| Q1 25 | — | $287.9M | ||
| Q4 24 | $40.9M | $311.4M | ||
| Q3 24 | — | $565.0M | ||
| Q2 24 | $-125.5M | $340.6M | ||
| Q1 24 | — | $166.2M |
自由现金流率ARGXIT
| Q4 25 | 13.0% | 15.4% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | 20.1% | 20.6% | ||
| Q1 25 | — | 18.8% | ||
| Q4 24 | 3.0% | 18.2% | ||
| Q3 24 | — | 38.1% | ||
| Q2 24 | -13.9% | 21.4% | ||
| Q1 24 | — | 11.3% |
资本支出强度ARGXIT
| Q4 25 | 0.0% | 1.4% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | 0.3% | 2.1% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | 0.1% | 1.4% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | 0.1% | 1.8% | ||
| Q1 24 | — | 1.5% |
现金转化率ARGXIT
| Q4 25 | 0.37× | 1.22× | ||
| Q3 25 | — | 8.45× | ||
| Q2 25 | 0.87× | 1.59× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | 0.05× | 0.84× | ||
| Q3 24 | — | 1.42× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.90× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARGX
暂无分部数据
IT
| Transferred Over Time | $1.3B | 73% |
| Conferences | $286.2M | 16% |
| Consulting | $133.6M | 8% |
| Other | $52.3M | 3% |
